Gilead Sciences, Inc. (GILD) insider trading.
In Q3 2026, insiders at Gilead Sciences, Inc. reported 49 non-derivative transactions on 18 Forms 3, 4 and 5: 0 open-market purchases and 26 sales worth $15.4M.
- Transactions
- 49
- Purchases (P)
- 0
- Sales (S)
- 26
- Net shares, P minus S
- -111,000
- Insiders
- 8
- Last filed
- 2026-09-23
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Mercier Johanna | Officer · Chief Comm & Corp Aff Officer | 10 | 0 | 6 |
| O'Day Daniel Patrick | Director, Officer · Chairman & CEO | 10 | 0 | 8 |
| Bluestone Jeffrey | Director | 10 | 0 | 5 |
| Welters Anthony | Director | 6 | 0 | 4 |
| Dickinson Andrew D | Officer · Chief Financial Officer | 5 | 0 | 3 |
| Cain Wettan Keeley M | Officer · EVP Gen Counsel, Legal & Comp | 4 | 0 | 0 |
| Burkhart Erin | Officer · SVP, Controllership | 2 | 0 | 0 |
| Berger Dietmar | Officer · Chief Medical Officer | 2 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-22 | Burkhart Erin | F (D) | 768 | $152.67 | 1,455 | Form 4 |
| 2026-09-22 | Burkhart Erin | M (A) | 2,223 | — | 2,223 | Form 4 |
| 2026-09-15 | Dickinson Andrew D | S (D) | 3,000 | $145.29 | 164,096 | Form 4 |
| 2026-09-15 | Mercier Johanna | S (D) | 1,600 | $143.69 | 118,084 | Form 4 |
| 2026-09-15 | Mercier Johanna | S (D) | 800 | $144.46 | 117,284 | Form 4 |
| 2026-09-15 | Mercier Johanna | S (D) | 600 | $145.29 | 116,684 | Form 4 |
| 2026-09-10 | Dickinson Andrew D | F (D) | 1,347 | $144.81 | 167,096 | Form 4 |
| 2026-09-10 | Dickinson Andrew D | M (A) | 2,797 | — | 168,443 | Form 4 |
| 2026-09-10 | O'Day Daniel Patrick | F (D) | 4,230 | $144.81 | 581,683 | Form 4 |
| 2026-09-10 | O'Day Daniel Patrick | M (A) | 8,780 | — | 585,913 | Form 4 |
| 2026-09-10 | Berger Dietmar | F (D) | 263 | $144.81 | 19,522 | Form 4 |
| 2026-09-10 | Berger Dietmar | M (A) | 533 | — | 19,785 | Form 4 |
| 2026-09-10 | Mercier Johanna | M (A) | 2,797 | — | 121,031 | Form 4 |
| 2026-09-10 | Mercier Johanna | F (D) | 1,347 | $144.81 | 119,684 | Form 4 |
| 2026-09-10 | Cain Wettan Keeley M | M (A) | 590 | — | 9,044 | Form 4 |
| 2026-09-10 | Cain Wettan Keeley M | F (D) | 285 | $144.81 | 8,759 | Form 4 |
| 2026-09-01 | O'Day Daniel Patrick | S (D) | 1,600 | $147.51 | 590,533 | Form 4 |
| 2026-09-01 | O'Day Daniel Patrick | S (D) | 7,992 | $148.36 | 582,541 | Form 4 |
| 2026-09-01 | O'Day Daniel Patrick | S (D) | 5,408 | $149.38 | 577,133 | Form 4 |
| 2026-08-26 | Welters Anthony | S (D) | 4,600 | $148.82 | 12,894 | Form 4 |
| 2026-08-26 | Welters Anthony | S (D) | 6,880 | $148.82 | 12,894 | Form 4 |
| 2026-08-26 | Welters Anthony | S (D) | 3,402 | $148.24 | 19,774 | Form 4 |
| 2026-08-26 | Welters Anthony | S (D) | 3,118 | $148.31 | 17,494 | Form 4 |
| 2026-08-26 | Welters Anthony | M (A) | 10,282 | $61.35 | 23,176 | Form 4 |
| 2026-08-26 | Welters Anthony | M (A) | 7,718 | $60.67 | 20,612 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | M (A) | 1,658 | $67.45 | 11,724 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | S (D) | 1,658 | $145.73 | 10,066 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | M (A) | 26 | $67.45 | 10,092 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | S (D) | 1,816 | $144.92 | 10,066 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | M (A) | 1,165 | $67.45 | 11,231 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | S (D) | 1,165 | $143.75 | 10,066 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | M (A) | 1,816 | $67.45 | 11,882 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | S (D) | 335 | $146.26 | 10,066 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | M (A) | 335 | $61.35 | 10,401 | Form 4 |
| 2026-08-20 | Bluestone Jeffrey | S (D) | 26 | $146.36 | 10,066 | Form 4 |
| 2026-08-17 | Dickinson Andrew D | S (D) | 3,000 | $138.36 | 165,646 | Form 4 |
| 2026-08-17 | Mercier Johanna | S (D) | 11,470 | $138.04 | 118,234 | Form 4 |
| 2026-08-17 | Mercier Johanna | S (D) | 16,530 | $137.37 | 129,704 | Form 4 |
| 2026-08-17 | Mercier Johanna | M (A) | 1,890 | $72.34 | 146,234 | Form 4 |
| 2026-08-17 | Mercier Johanna | M (A) | 23,110 | $66.64 | 144,344 | Form 4 |
| 2026-08-10 | Cain Wettan Keeley M | F (D) | 2,908 | $133.06 | 8,454 | Form 4 |
| 2026-08-10 | Cain Wettan Keeley M | M (A) | 6,002 | — | 11,362 | Form 4 |
| 2026-08-03 | O'Day Daniel Patrick | S (D) | 6,700 | $129.66 | 600,433 | Form 4 |
| 2026-08-03 | O'Day Daniel Patrick | S (D) | 600 | $131.34 | 592,133 | Form 4 |
| 2026-08-03 | O'Day Daniel Patrick | S (D) | 7,700 | $130.8 | 592,733 | Form 4 |
| 2026-07-15 | Dickinson Andrew D | S (D) | 3,000 | $129.93 | 168,646 | Form 4 |
| 2026-07-15 | Mercier Johanna | S (D) | 3,000 | $129.92 | 121,234 | Form 4 |
| 2026-07-01 | O'Day Daniel Patrick | S (D) | 11,900 | $126.09 | 610,233 | Form 4 |
| 2026-07-01 | O'Day Daniel Patrick | S (D) | 3,100 | $127.08 | 607,133 | Form 4 |
Transaction codes in this quarter
Get GILD insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=882095&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · GILD company page · Gilead Sciences, Inc. on SEC.gov
Questions
Are insiders buying or selling Gilead Sciences, Inc. (GILD)?
In Q3 2026, insiders at Gilead Sciences, Inc. reported 49 non-derivative transactions on 18 Forms 3, 4 and 5: 0 open-market purchases and 26 sales worth $15.4M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Gilead Sciences, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/gild.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.